Clinical Trial Update: Randomized Controlled Trial of Dexmedetomidine for the Treatment of Intensive Care Unit (ICU) Delirium [Phase 2]

View source ↗

Summary

Phase 2 randomized controlled trial evaluating dexmedetomidine for the treatment of ICU delirium has completed, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delirium

Drugs mentioned

• Dexmedetomidine (Dexmedetomidine)

Snippet

Sponsor: Brigham and Women's Hospital | Conditions: Delirium, Agitation | Phase 2 | Status: COMPLETED | Results posted: 2017-05-09